In the world of chemistry the majority of reactions are well known
and have been around for a very long time producing similar
compounds. It is not very often that a completely new reaction
methodology comes along which can turn something...
Labcyte and Deerac Fluidics, which both make liquid handling
devices, albeit for different low-volume ranges, have decided to
merge and combine their technologies.
A new enterprise in the United Arab Emirates (UAE) is establishing
itself as the region's first pharmaceutical-focused third party
logistics (3PL) provider.
Another sharp decline in biomedical production saw overall
manufacturing output in Singapore fall for the second month running
in December, prompting fears that the heavily trade-reliant economy
could buckle under a looming US recession.
MiddleBrook Pharmaceuticals secured a crucial endorsement for its
Pulsys oral drug delivery system last week when the US Food and
Drug Administration (FDA) approved the company's lead pipeline
product, Moxatag, as a once-daily...
AstraZeneca has announced a new collaboration with the University
of Texas' MD Anderson Cancer Center as it steps up its reliance on
external partners.
Nabi Biopharmaceuticals this week announced that is considering a
possible sale or merger of the company, with 'multiple entities'
apparently interested in the business.
US scientists have found a way of stopping quantum dots from
'blinking'. The resultant increase in light intensity could make
them more useful in medical research.
Tecan and PerkinElmer have taken the opportunity to showcase new
plate reader products at LabAutomation 2008, firmly re-establishing
themselves as major players in this popular and lucrative sector.
With the price of crude oil going up almost every day it is no
surprise that this has a knock-on effect to the price of raw
materials for the pharmaceutical and chemical industries. But DSM
and Roquette have developed a process that...
Lonza has revealed a profit hike for the full year of 2007,
reflecting the fruit of its "revised growth strategies"
across its business units, said the firm, which also announced its
"innovations" for future growth...
Eli Lilly has released a statement strongly objecting to
implications made in a New York Times article that it has
suppressed results of negative clinical trials.
The world's most powerful transmission electron microscope has been
turned on in the US, with single-atom resolution bringing within
reach the ability to analyse chemicals simply by looking at them.
Israeli generics behemoth Teva is following the market and banking
on the promise of biologics with its purchase of Human Genome
Sciences biotech spin-off, CoGenesys.
Vapourtec has made two new additions to its Flow Chemistry platform
available as the company make headway in an emerging field, which
aims to speed up laboratory processes in drug discovery.
Novartis has announced the US approval of its first-in-class blood
pressure med Tekturna (aliskiren) combined with a diuretic in a
single-tablet formulation.
After seven months of offers, refusals and heated exchanges, it
seems an increased offer from Roche has finally persuaded the
powers that be at Ventana to sell up.
GE Healthcare has reported its fourth quarter and full year
financial results in a tough 12 months that have seen the
laboratory imaging and diagnostics company feel the full force of
US Government regulatory pressure.
Dublin-based contract research organisation (CRO) Icon Clinical
Research has forayed further into Eastern Europe with the opening
of three new offices there.
Canadian vaccine specialist ImmunoVaccine Technologies (IVT) has
scored a multi-million dollar grant to go towards developing its
potent immune enhancement systems.
Australian firm Fluorotechnics wants to bolster the sales of its
proteomics products in Japan and so has signed up Osaka firm Wako
Pure Chemical Industries to help.
Scientists have discovered a technique that can ensure lab samples
stay at the right pH, even when frozen and the discovery could
bring into doubt previously published research.
New UK Government proposals to scrap Capital Gains Tax (CGT) relief
will stifle life science innovation, according to a group of
biotech small and medium enterprises (SMEs).
Processing specialist Sartorius Stedim Biotech today announced a
cooperation and supply deal with systems manufacturing firm Paul
Mueller Company for the US market, with a production facility in
Pennsylvania set to close as a result.
Product recalls in the UK due to health and safety concerns have
shot up to their highest level, with the rise in outsourcing to
China finger pointed for much of the blame.
Pfizer Japan is cleaning out its closet, selling a range of its
"surplus" biotech and pharmaceutical lab equipment via an online
auction, a method that is slowly catching on in the country.
The Biotechnology Industry Organization has fired a broadside at
French President Nicolas Sarkozy after he banned a GM corn crop
without, it says, 'any scientific basis'.
Chemical and intermediates firm Lanxess has announced that its
subsidiary Saltigo is the proud new owner of a site in Washington
in the US, formerly used by Eli Lilly subsidiary, ICOS.
Pfizer is vowing to fight on as Nigerian court battles against its
subsidiary in the country wage on over its alleged involvement in
child deaths through experimentation over a decade ago.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving Encorium Group,
Holmes Biopharma and Novotech.
Novartis has been keen to shout about data published this week in
the Journal of the American Medical Association (JAMA)
that backs up claims that it has developed the first vaccine to
protect infants against the most common meningitis...
Japan's number two pharma firm has elected to set up significant
operations in India - the first Japanese pharma company planning to
plant itself in the country on such a scale.
Diagnostics firm bioMérieux has announced plans to shift activities
at its facility in the Netherlands to France, shutting down the
Dutch site as it continues to haemorrhage cash.
US firms Multispan and Promega have paired up to develop assay
tools for G-protein coupled receptor (GPCR) screening, in the hope
of speeding up drug discovery on these, the most popular protein
targets in pharma.
Skin cancer detection specialists DermTech have decided to turn
their hand to acne after signing an agreement with Stiefel
Laboratories to identify spot-causing genes.
Roche today announced a handful of new charitable technology
transfer agreements with manufacturers in Africa and Asia, allowing
local production of generic HIV drugs.
Drug delivery specialist Antares Pharma has landed its fourth deal
with Israeli generics behemoth Teva, this time to develop a novel
pen injector for two Teva products.
Applied Biosystems (ABI) has teamed up with several service
providers to increase scientists' access to its SOLiD genome
analysis system and hopefully save them some money.
Millipore has announced the first fruit of its collaboration with
testing specialist Gen-Probe, with the launch of a new contaminant
detection system for biopharmaceutical manufacturers.